| Financial Year |
March 31 2023 |
| Monetary Funds |
6,848,866,763.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,099,889,411.00 |
| Accounts Receivable |
180,467,685.40 |
| Advances to Suppliers |
556,344,124.41 |
| Other Receivables |
467,979,713.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,728,465,499.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
292,630,202.79 |
| Total Current Assets |
16,199,812,446.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,024,516,568.76 |
| Investment Properties |
-- |
| Fixed Assetes |
38,799,675,012.16 |
| Under-construction Projects |
4,812,659,816.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,670,128,450.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,948,244.04 |
| Deferred Income Tax Assets |
827,265,470.09 |
| Other Non-Current Assets |
1,589,854,404.70 |
| Sub-Total of Non-Current Assets |
52,974,508,020.32 |
| Total Assets |
69,174,320,466.84 |
| Short-Term Loans |
4,194,973,107.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,210,702,808.28 |
| Accounts Payable |
11,043,515,874.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
389,210,095.25 |
| Taxes Payable |
85,461,343.74 |
| Interest Payable |
-- |
| Dividend Payable |
1,694,029.60 |
| Other payables |
666,142,354.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,621,393,531.22 |
| Other Current Liabilities |
277,735,447.96 |
| Sub-Total of Current Liabilities |
28,691,247,248.62 |
| Long-term Loans |
6,842,499,999.95 |
| Bonds Payable |
99,000,000.00 |
| Long-Term Accounts Payable |
88,972,140.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
21,405,522.97 |
| Deferred Income Tax Liabilities |
151,541,525.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,946,026,437.58 |
| Total Liabilities |
37,637,273,686.20 |
| Paid-In Capital(Or Share Stock) |
10,698,849,554.00 |
| Capital Surplus |
8,123,125,083.01 |
| Surplus Reserve |
961,870,154.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,747,103,018.49 |
| Minority Stockholder's Interest |
9,994,870,446.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,542,176,334.23 |
| Owner's Equity（Stockholder's Equity） |
31,537,046,780.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
69,174,320,466.84 |
